Brazilian Foreign, Health Ministries Ready To Support Dialogue On Russia's Sputnik V
Muhammad Irfan Published May 04, 2021 | 10:50 AM
RIO DE JANEIRO (UrduPoint News / Sputnik - 04th May, 2021) � Foreign and health ministries of Brazil are willing to continue the conversation about Russia's coronavirus vaccine Sputnik V so it could be authorized for use in the country.
Last week, the Brazilian health regulator Anvisa rejected a regional government request to import the Russian-made vaccine. The Russian Direct Investment Fund (RDIF), which markets Sputnik V abroad, said it believes the decision may be "politically motivated," citing a US Department of Health report that the United States had attempted to persuade Brazil not to use the vaccine. On Thursday, the manufacturers of Sputnik V said they would launch a legal defamation suit against Anvisa for "knowingly spreading false and inaccurate information."
"[The foreign and health ministries are willing] to support the current dialogue, while respecting the autonomy of Anvisa, so that Sputnik V will strengthen the country's national coronavirus vaccination program after it is approved in Brazil," the ministries said in a joint statement.
The ministries have also noted the readiness of Anvisa, the RDIF, and the Gamaleya Institute, the vaccine's developer, to clarify the remaining issues, which includes providing additional documents.
In April, governors of Brazil's northeastern states announced their intention to appeal to the Supreme Court if they did not receive a response from Anvisa on the delays in Sputnik V's import approval. On April 13, Supreme Judge Ricardo Lewandowski gave Anvisa until the end of this month to make a decision.
Sputnik V, the world's first registered coronavirus vaccine, has been approved for emergency use in 60 countries across the globe. The efficacy of the vaccine stands at 97.6%, based on the latest analysis of data on the post-vaccination infection percentage among 3.8 million vaccinated Russians. It is higher than the 91.6% efficacy shown in an interim analysis from the trial published in The Lancet in early February.
Related Topics
Recent Stories
Punjab CM inaugurates Pakistan’s first Virtual Women Police Station
Dutch model Donny Roelvink embraces Islam
Experts raise concerns over introduction of 10-stick packs
Iranian president arrives in Karachi
Law Minister expresses Govt's resolve to address issue of missing persons
Rizwan’s batting order may be changed: Sources
Nawaz Sharif to visit Guangzhou exhibition in China
FM Dar not traveling to China: Foreign Office
PM takes notice of deliberate delay in tax cases
Iranian President visits Allama Iqbal’s mausoleum
Iranian President arrives in Lahore today
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 23 April 2024
More Stories From World
-
Maduro announces return of UN rights office to Venezuela
17 minutes ago -
Large crowds march against Argentina public university cuts
27 minutes ago -
Football: Italian Cup result
57 minutes ago -
Football: English Premier League result
57 minutes ago -
Talks on global plastic treaty begin in Canada
57 minutes ago -
US markets rise for second straight day as sentiment improves
57 minutes ago
-
Asia hit hardest by climate change, extreme weather: UN weather agency
1 hour ago -
Migrant boat capsizes off Djibouti leaving 21 dead
7 hours ago -
Tesla profits tumble 55% as EV sales under pressure
7 hours ago -
Talks on global plastic treaty begin in Canada
8 hours ago -
Migrant deportations loom after parliament passes UK-Rwanda plan
8 hours ago -
Macron in last-ditch bid to halt EU vote battering
8 hours ago